Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Accelerating corporate data center artificial intelligence capital expenditures, projected to rise from $850B in 2026 to $1.3T in 2027, could drive substantial debt and equity underwriting fee velocity, lifting valuation toward Potential value of $155.02.
A macroeconomic stagflation shock driving the terminal multiple below 10.4x.
We rate Morgan Stanley as a Sell. The shares trade at a substantial premium to fundamental value, leaving investors with an unfavorable risk-reward balance.4
Our rating is Sell. For an ordinary investor, this means avoiding new share purchases and selling or trimming existing holdings to preserve capital against potential downside.
On September 21, 2026, the stock was priced at $206.12. This price sits 72.2% above our Fair value of $119.68, representing an upside of -41.9%. It also exceeds our Potential value of $155.02.4
The primary downside risk is a slowdown in capital markets underwriting combined with fee compression in wealth management. If market declines reduce asset values, advisory fees shrink while dealmaking revenue falls. Investors would observe this risk unfolding if Institutional Securities quarterly revenue drops below $6.0B for two consecutive quarters.58
The business could outperform if corporate artificial intelligence infrastructure investments surge to $1.3T in 2027. That expansion would lift underwriting fees and investment banking profits toward Potential value of $155.02. However, this potential upside remains secondary to the substantial valuation premium.5
Wealth management client inertia and multi-product corporate relationships anchor $31.75B in FY2025 fee-based revenue with demonstrated pricing leverage in specialized products.58
Tier-one underwriting brand and institutional trust enable the firm to intermediate complex multi-year corporate capital requirements.5
Resurgent debt and equity underwriting driven by corporate refinancing and an expanding IPO backlog.5
We rate Morgan Stanley a Sell because the share price of $206.12 on September 21, 2026 stands at a 72.2% premium to our Fair value of $119.68, leaving no margin of safety against potential capital markets contractions.4
Institutional Securities provides a variety of products and services to corporations, governments, financial institutions and ultra-high net worth clients. Investment Banking services consist of capital raising and financial advisory services, including the underwriting of debt, equity securities and other products, as well as advice on mergers and acquisitions, restructurings and project finance. Its Markets business, which comprises Equity and Fixed Income, provides sales, financing, prime brokerage, market-making, and Asia wealth management services and holds certain business-related investments. MORGAN STANLEY is a global financial services firm that maintains significant market positions in each of its business segments: Institutional Securities, Wealth Management and Investment Management. Through its subsidiaries and affiliates, the company provides a wide variety of products and services to a large and diversified group of clients and customers, including corporations, governments, financial institutions and individuals.
Under a severe stagflation scenario, falling asset prices cut wealth management advisory fees while institutional dealmaking freezes. Negative FY2025 operating cash flow of -$17.89B limits capital flexibility, forcing multiple de-rating.
Morgan Stanley maintains a narrow economic moat grounded in high switching costs across wealth management and intangible brand assets in institutional securities.
While wealth advisory fees generate dependable baseline earnings, aggressive pricing from independent registered investment advisors and point-to-point capital placement present enduring competitive friction.
FY2025 return on equity of 15.1% exceeds the 9.83% cost of equity, reflecting durable economic profit.2
None of the valuation methods used to calculate Fair value relies on a separate assumption about how long the competitive advantage lasts.
The highlighted cell is Fair value when every assumption sits at its base level ($119.68). Each row and column shows what Fair value becomes when one assumption moves.
A free-cash-flow drop test is not available in this run; use the discount-rate and terminal-growth grid as the primary valuation pressure test.
A cyclical earnings beat confirms dealmaking recovery but only narrows the substantial premium over Fair value $119.68.
Meeting expectations preserves the baseline projection while the shares trade at $206.12, substantially above Fair value $119.68.
Industry capital expenditures stand at 1.7x depreciation and 1.6% of revenue. As supply and capacity data are unavailable, the cycle perspective is demand-led and evidence-limited.
Resurgent debt and equity underwriting driven by corporate refinancing and an expanding IPO backlog.
Elevated interest rates and geopolitical uncertainty restrict corporate advisory activity and suppress trading volumes.
With the stock trading at $206.12 as of 2026-09-21, representing a 72.2% premium to Fair value of $119.68, zero portfolio exposure is recommended under our Sell rating.4
Eliminate downside exposure by divesting existing equity holdings, avoiding unhedged long exposure, and managing financial sector beta via liquid index options.
The shares traded at $206.12 on September 21, 2026, standing 72.2% above our Fair value of $119.68, offering no margin of safety.4
Although the firm paid $6.59B in dividends in FY2025 ($4.60 per share), the elevated share price compresses yield while negative operating cash flow of -$17.89B constrains capital returns.7
Even with positive corporate technology financing trends, the price exceeds our Potential value of $155.02, skewing risk-reward downward.
We recommend a Sell rating on Morgan Stanley. The stock traded at $206.12 on September 21, 2026, standing 72.2% above our Fair value of $119.68.4
While wealth management generates recurring fee income, prevailing market levels leave investors vulnerable to multiple contraction if underwriting activity slows or advisory fees compress.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
The records this analysis drew on, as they stood when it was run.
The Bear scenario envisions persistent macroeconomic stagflation, subdued capital market activity, and fee compression across wealth management. Underwriting freezes and elevated capital costs reduce earnings power, driving substantial multiple contraction. Confirmation would be marked by consecutive quarters of declining institutional revenue and net asset outflows.
Macroeconomic stagflation freezes corporate capital markets underwriting and compresses the terminal valuation multiple toward Goldman Sachs at 12.96x forward earnings, triggering valuation contraction if the terminal multiple falls below 10.4x.3
Monetary tightening and regulatory capital buffer expansions push the cost of equity above 11.83% against strict cost of equity of 9.94% and pre-tax cost of debt of 19.55%, triggering steep dividend discount valuation declines.2
A multi-year equity market contraction and discount RIA fee pricing lower 5-year annual revenue growth below -2.0% because advisory fees depend on asset price levels, depressing operating margins toward FY2023 trough levels of 13.38%.5
The five developments that would weaken our investment case.
Negative revenue growth indicates that market declines or price discounting by competing advisors have overwhelmed net new asset inflows, eroding the fee-based compounding engine that stabilizes firm profitability across market cycles.
Current:$31.75B in FY2025
Alert ifAnnual revenue growth falls below 0.0% over any 12-month period
A steep drop in operating margin reflects loss of operating leverage across institutional trading and underwriting, demonstrating that fixed compensation and technology infrastructure spending cannot be quickly flexed downward during cyclical volume downturns.
Current:19.09% in FY2025
Alert ifOperating margin drops below 15.0% over a trailing four-quarter period
Sustained quarterly revenue declines reveal a deep freeze in debt and equity underwriting alongside muted secondary market-making volumes, impairing the primary driver of upside operating leverage and earnings velocity.
Current:$33.08B in FY2025
Alert ifQuarterly revenue falls below $6.0B for two consecutive quarters
Contraction in international revenue share signals that cross-border dealmaking and global corporate intermediation are succumbing to regulatory fragmentation and trade barriers, curtailing the firm's global reach advantage.
Current:15.4% of consolidated revenue in FY2025
Alert ifCombined Asia and EMEA revenue falls below 10.0% of total revenue over a full fiscal year
Persistent cash outflows highlight balance sheet funding friction and expanding working capital absorption in broker-dealer assets, reducing surplus liquidity available for share repurchases and cash dividend payouts.
Current:-$17.89B in FY2025
Alert ifOperating cash flow remains negative for a second consecutive fiscal year
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
Apply a terminal P/E to the dated forward EPS path, then discount that future share value back to the analysis date.
Discount the explicit dividend path and its Gordon-growth terminal value at cost of equity.
Limitation: Terminal value is 71.9% of this model's value, above the 60% level at which the methodology flags concentration; the value leans on the years beyond the explicit forecast.
Solve for the growth rate that makes the model value equal the report-date share price.
The Base scenario targets $119.68 with a probability of 55.0%, implying an expected return of -41.9% from $206.12. This path assumes steady wealth fee growth and normalized institutional trading revenues. Disconfirmation would occur if underwriting dealflow stalls or advisory margins compress over coming quarters.
The Bull scenario targets $155.02 with a probability of 20.0%, offering an expected return of -24.8% from $206.12. This outcome requires surging corporate capital expenditures and an active IPO calendar driving strong institutional operating leverage. Disconfirmation would emerge if corporate financing bypasses traditional syndicates into direct private deals.
An operational shortfall indicates softening fee realization and threatens multiple contraction toward the valuation floor.
Earnings quality reflects durable fee-based revenue in wealth management, while operating cash flow experiences periodic working capital fluctuations from broker-dealer trading asset financing.7
Sustained net asset inflows expand fee-earning balances, driving recurring revenue that buffers the firm against cyclical underwriting downturns.
Conversion of deal pipeline into completed transactions drives substantial operating leverage and fee generation in Institutional Securities.
Discipline in compensation and technology expenditures ensures revenue gains drop down to pretax income and equity returns.
Cross-border financing mandates in Asia and Europe provide diversification away from domestic capital market fluctuations.
Retiring common shares reduces diluted share count and steadily enhances earnings per share over long horizons.
| $57.78B |
| $62.48B |
| $88.29B |
| $103.15B |
| $114.98B |
| +18.8% |
| Gross profit | $56.41B | $49.93B | $50.14B | $57.36B | $65.62B | +3.9% |
| Operating income | $19.67B | $14.09B | $11.81B | $17.60B | $21.95B | +2.8% |
| Net income | $15.03B | $11.03B | $9.09B | $13.39B | $16.86B | +2.9% |
| EPS (diluted) | $8.03 | $6.15 | $5.18 | $7.95 | $10.21 | +6.2% |
| EBITDA | $23.88B | $18.09B | $16.07B | $22.76B | $26.61B | +2.7% |
| R&D | — | — | — | — | — | — |
| SG&A | $24.63B | $23.05B | $24.21B | $26.18B | $29.07B | +4.2% |
Reported FY2025 operating cash flow of -$17.89B and free cash flow of -$20.79B reflect balance sheet financing flows and trading asset inventory adjustments typical of major broker-dealers, rather than structural operational cash deficits.67
Capital return centers on cash dividends of $6.59B in FY2025 and repurchases, shrinking diluted average shares from 1,646M in FY2023 to 1,592M in FY2025 and 1,570.6M shares outstanding in September 2026.
Durable wealth management advisory fees provide a solid earnings baseline, while institutional securities provides cyclical upside leverage during capital market recoveries.
FY2025 return on equity of 15.1% comfortably exceeds the 9.83% cost of equity.
Wealth Management delivered $31.75B in FY2025 revenue.
Stable fee streams insulate firm net income against cyclical dealmaking slowdowns.
Institutional Securities revenue rose to $33.08B in FY2025 with a 65% efficiency ratio in early 2026.
Underwriting recoveries expand operating margins directly into net income growth.
| Revenue | $34,470,000,000 |
|---|---|
| Cost of revenue | $13,220,000,000 |
| Gross profit | $21,250,000,000 |
| Operating expenses | $13,852,000,000 |
| Operating income | $7,398,000,000 |
| Non-operating items and tax | -$1,817,000,000 |
| Net income | $5,581,000,000 |
| Total assets | $1,420,270,000,000 |
|---|---|
| Cash | $111,695,000,000 |
| Current assets | $654,691,000,000 |
| Total liabilities | $1,307,618,000,000 |
| Current liabilities | $559,572,000,000 |
| Shareholders’ equity | $112,652,000,000 |
| Net income | $13,390,000,000 |
|---|---|
| Operating inflow | $20,173,000,000 |
| Depreciation and amortization | $5,161,000,000 |
| Stock-based compensation | $1,622,000,000 |
| Operating cash flow | $1,362,000,000 |
| Operating outflow | $18,811,000,000 |
| Cash available | $137,350,000,000 |
| Beginning cash | $89,232,000,000 |
| Financing inflow | $46,756,000,000 |
| Investing outflow | $29,460,000,000 |
| Capex | $3,462,000,000 |
| Other investing activities | $25,998,000,000 |
| Exchange-rate effect | $2,504,000,000 |
| Ending cash | $105,386,000,000 |
| Investing cash flow | -$29,460,000,000 |
| Financing cash flow | $46,756,000,000 |
Source: SEC EDGAR · Filed 2026-02-19 · SEC EDGAR
| Revenue by geography | Revenue | Share | YoY |
|---|---|---|---|
| Americas | $52.9B | 74.9% | 12.7% |
| Asia | $9.4B | 13.3% | 23.4% |
| EMEA | $8.3B | 11.8% | 15.7% |
Point-in-time financial data used in the 2026-09-22 analysis.
| Period | Revenue | EBITDA | Net income | Operating cash flow | Free cash flow | Capex | Depreciation and amortization | Stock-based compensation | Share repurchases | Dividends paid | Net debt issuance | Investing cash flow | Financing cash flow | Beginning cash | Ending cash | Cash and investments | Total debt | Operating margin | ROIC | WACC | ROIC − WACC spread |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $36B | $10.6B | $6B | $5.4B | $4.1B | $1.3B | $1.7B | $1.1B | — | $1.7B | — | -$19.5B | $7.4B | — | $77.4B | $352.1B | $164.8B | 24.6% | — | 4.4% | — |
| 2017-12-31 | $41.5B | $12.2B | $6.1B | -$4.5B | -$6.1B | $1.6B | $1.8B | $1B | — | $2.1B | — | -$12.4B | $16.3B | $77.4B | $80.4B | $348.4B | $191.1B | 25.0% | — | 4.7% | — |
| 2018-12-31 | $47.8B | $13.1B | $8.7B | $7.3B | $5.4B | $1.9B | $1.8B | $920M | — | $2.4B | — | -$22.9B | $24.2B | $80.4B | $87.2B | $392.6B | $188.1B | 23.5% | — | 9.0% | — |
| 2019-12-31 | $51.4B | $13.9B | $9B | $40.8B | $38.9B | $1.8B | $2.6B | $1.2B | — | $2.6B | — | -$33.6B | -$12B | $87.2B | $82.2B | $401.3B | $190.1B | 22.0% | — | 8.6% | — |
| 2020-12-31 | $49.7B | $18.2B | $11B | -$25.2B | -$26.7B | $1.4B | $3.8B | $1.3B | — | $2.7B | — | -$37.9B | $83.8B | $82.2B | $105.7B | $512.4B | $213.4B | 29.0% | — | 3.1% | — |
| 2021-12-31 | $57.8B | $23.9B | $15B | $34B | $31.7B | $2.3B | $4.2B | $2.1B | — | $4.2B | — | -$49.9B | $41.5B | $105.7B | $127.7B | $541.2B | $227.4B | 34.0% | — | 3.6% | — |
| 2022-12-31 | $62.5B | $18.1B | $11B | -$6.4B | -$9.5B | $3.1B | $4B | $1.9B | $10.9B | $5.4B | $37.6B | -$11.6B | $22.7B | $127.7B | $128.1B | $503.2B | $233.9B | 22.6% | — | 9.9% | — |
| 2023-12-31 | $88.3B | $16.1B | $9.1B | -$33.5B | -$36.9B | $3.4B | $4.3B | $1.7B | $6.2B | $5.8B | $13.6B | -$3.1B | -$2.7B | $128.1B | $89.2B | $492.5B | $260.5B | 13.4% | — | 11.1% | — |
| 2024-12-31 | $103.1B | $22.8B | $13.4B | $1.4B | -$2.1B | $3.5B | $5.2B | $1.6B | $4.2B | $6.1B | $28.1B | -$29.5B | $46.8B | $89.2B | $105.4B | $431.2B | $284.3B | 17.1% | — | 11.3% | — |
| 2025-12-31 | $115B | $26.6B | $16.9B | -$17.9B | -$20.8B | $2.9B | $4.7B | $1.9B | $5.8B | $6.6B | $39.8B | -$46.8B | $67.8B | $105.4B | $111.7B | $540B | $341.7B | 19.1% | — | 10.9% | — |
Morgan Stanley (MS) trades at 15.1x forward earnings against a peer median of 15.3x. The comparison uses 4 peers: The Goldman Sachs Group Inc., Robinhood Markets, Inc., The Charles Schwab Corporation and BlackRock Inc., as of 2026-09-21 to 2026-09-22.
| Corporate Artificial Intelligence Infrastructure Financing | positive | Surging corporate spending on computing infrastructure expands multi-year private placement and public underwriting mandates. |
| Private Credit and Point-to-Point Corporate Financing | negative | Direct capital raising among non-bank ecosystem participants bypasses traditional investment banking fee pools. |
Well anchored by top-tier investment banking distribution and the leading Americas wealth management network.8
| Review valuation parameters |
| Permits entry aligned with fundamental earnings power and normalized dividend yield. |
| Consider initial accumulation | Provides an attractive margin of safety anchored in regulated bank cash dividend capacity. |
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
| Robinhood Markets, Inc. |
| $110.9B |
| 36.4x |
| 22.5x |
| 23.6% |
| 43.9% |
| SCHW | The Charles Schwab Corporation | $184.8B | 13.7x | 7.1x | 20.3% | 52.3% |
| BLK | BlackRock Inc. | $177.1B | 17.0x | 6.5x | 15.6x | 12.3% | 35.1% |
